Crossmark

Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety

Crossref DOI link: https://doi.org/10.1007/s10147-019-01414-0

Published Online: 2019-02-18

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tanioka, Hiroaki

Honda, Michitaka https://orcid.org/0000-0003-3492-9881
Tanaka, Chihiro

Morita, Yoshitaka

Ishibashi, Keiichiro

Kato, Takeshi

Matsuda, Chu

Kataoka, Masato

Satake, Hironaga

Munemoto, Yoshinori

Kobayashi, Kenji

Takahashi, Masazumi

Nakata, Ken

Sakamoto, Junichi

Oba, Koji

Mishima, Hideyuki
License Information

Text and Data Mining valid from 2019-02-18
More Information

Article History

Received: 1 November 2018

Accepted: 6 February 2019

First Online: 18 February 2019

Compliance with ethical standards

:

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below